돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 354135생성일: 2026년 10월 27일

Diisopropylethylamine → N-(1-(Phenylmethyl)piperid-4-yl)-N-(3-phenyl-2-propen-1-yl)-4-methoxyphenylacetamide

https://huagongshe.com/reaction/354135

반응식

참여 물질

역할이름HCID투입량
반응물DiisopropylethylamineHCID 81531—
반응물1-Benzyl-4-piperidylamineHCID 415852—
반응물CinnamaldehydeHCID 637511—
반응물4-Methoxyphenylacetyl chlorideHCID 2734688—
용매Acetic AcidHCID 176—
용매MethanolHCID 887—
용매WaterHCID 962—
용매DichloromethaneHCID 6344—
용매Sodium cyanoborohydrideHCID 5003444—
생성물N-(1-(Phenylmethyl)piperid-4-yl)-N-(3-phenyl-2-propen-1-yl)-4-methoxyphenylacetamideHCID 66659302—

반응 단계

To a solution of 4-amino-N-benzylpiperidine (200 mg, 1.05 mmol) in methanol (2 ml) was added trans-cinnamaldehyde (211 mg, 1.6 mmol), followed by Acetic acid in methanol (1 M, 1.4 ml) and sodiumcyanoborohydride in methanol (0.3 M, 4.4 ml). The reaction mixture was stirred at room temperature. After 48 h, water (2 ml) was added. The mixture was stirred for another 2 h before concentrated and redissolved in diethyl ether (20 ml). The organic layer was extracted with HCl (0.1 N, 2×10 ml). The combined aqueous layers were treated with NaOH (0.2 N) until basic (pH>8). The mixture was extracted with dichloromethane (2×10 ml). The combined organic layers were dried (Na2SO4) and concentrated. The crude product, which was used without any further purification, was dissolved in dichloromethane (5 ml). Diisopropylethylamine (284 mg, 2.1 eq.) was added, followed by 4-methoxyphenylacetyl chloride (387 mg, 2.0 eq). The reaction mixture was stirred at room temperature. After 18 h, water (2 ml) was added. After additional 2 h dichloromethane (10 ml) was added. The mixture was extracted with NaOH (0.2 N, 3×15 ml), and water (15 ml). The organic layer was dried (Na2SO4) and concentrated. The crude product was redissolved in methanol (2 ml) and added on to a column carrying strongly acidic cation exchange resin (0.3 mmol/g resin), which was washed with methanol (3×6 ml), and eluted with 10% NH3 in methanol, and concentrated to give the title compound. 13C-NMR (CDCl3): δ 28.5, 38.1, 46.6, 47.4, 50.9, 54.7, 62.9, 113.7, 125.5, 126.4, 126.6, 127.4, 127.9, 128.5, 128.6, 129.6, 130.0, 135.2, 135.3, 138.0, 158.2, 173.2.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06756393B2
출처 데이터셋uspto-grants-2004_06
ORD IDord-6e14d48768b449b2a76730a6e3b18d87
출처 메모uspto-grants-2004_06